ReviewOncology letters2020
Improving the overall diagnostic rate of early gastric cancer by managing family members with hereditary cancer syndromes.
Review in Oncology letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The 5-year survival rate of early gastric cancer (EGC) is significantly higher compared with that of advanced gastric cancer; however, the general diagnostic rate of EGC remains low in certain regions. The discovery of novel methods for diagnosing EGC will be beneficial for the general population. Among all gastric cancers, ~90% are sporadic, 10% are characterized as familial aggregation, and 3-5% of gastric cancer is attributed to genetic predisposition. Compared with sporadic cancer types, hereditary cancer syndromes (HCS) are usually characterized by the development of cancer at an early age. The present study proposes an approach for promoting the diagnostic rate of EGC in the general population by managing individuals with a family history of HCS and germline mutations of susceptibility genes. The proposed management strategy has three steps: i) Establish family history archives of the general population to screen families with individuals who have HCS; ii) recommend genetic testing for the individuals among the selected families to screen for high-risk EGC, (i.e., with HCS family history and genetic mutations); and iii) perform active routine surveillance for selected individuals to improve the overall diagnostic rate of EGC in the general population. Individuals with a positive family history should undergo the process presented above early in life, while those with a negative history may undergo routine inspection when necessary. With advances in the medical field and reductions in the cost of genetic testing, the diagnostic rate of EGC may be improved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.